+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Kyphoplasty Market Size, Share & Industry Trends Analysis Report By Product Type (Accessories and Kyphoplasty Systems), By Indication (Osteoporosis and Others), By End User, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 81 Pages
  • July 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5645319
The Europe Kyphoplasty Market is expected to witness market growth of 5.8% CAGR during the forecast period (2022-2028).

A wide variety of bone cement has so far been authorized for use in clinical settings, and several of them have been applied during balloon kyphoplasty procedures. The development of balloon kyphoplasty cement's new technological advancements is dependent on cutting-edge ideas and interdisciplinary expertise. The balloon kyphoplasty indications will probably be expanded with the introduction of innovative biodegradable & mechanically matched bone cement, supporting segment expansion. A major trend in the kyphoplasty market has been proven to be the inclination for less intrusive procedures.

Furthermore, rising healthcare spending, increasing demand for minimally invasive orthopedic surgery, & better health reimbursements are predicted to propel market expansion throughout projected period. The rise of the kyphoplasty market is also projected to be fueled by an increase in the frequency of spine fractures. By increasing price transparency, holding hospitals responsible, & ensuring that consumers have access to the information they need to make fully informed decisions about their health care, CMS is concentrating its efforts.

Due to the continued acceptance of better and more expensive kyphoplasty devices, the market for these systems in Europe, namely in Germany and Italy, is anticipated to expand at the quickest rate throughout the forecast period. One of the surgical specialties in the Europe region that is evolving the fastest is likely spine surgery. It combines as the "bastard offspring" of neurosurgery and orthopedics. Being the result of two specializations has challenges, but it also provides numerous opportunities.

The Germany market dominated the Europe Kyphoplasty Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $55.6 million by 2028. The UK market is anticipated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 6.6% during (2022 - 2028).

Based on Product Type, the market is segmented into Accessories and Kyphoplasty Systems. Based on Indication, the market is segmented into Osteoporosis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, MicroPort Scientific Corporation, IZI Medical Products, LLC (Landauer, Inc.), Merit Medical Systems, Inc., Jiangsu Changmei Medtech Co. Ltd., G21 S.r.l., Seawon Meditech Co., Ltd., joimax® GmbH and Taeyeon medical Co., Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

  • Accessories
  • Kyphoplasty Systems

By Indication

  • Osteoporosis
  • Others

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Stryker Corporation
  • MicroPort Scientific Corporation
  • IZI Medical Products, LLC (Landauer, Inc.)
  • Merit Medical Systems, Inc.
  • Jiangsu Changmei Medtech Co. Ltd.
  • G21 S.r.l.
  • Seawon Meditech Co., Ltd.
  • joimax® GmbH
  • Taeyeon medical Co., Ltd.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Kyphoplasty Market, by Product Type
1.4.2 Europe Kyphoplasty Market, by Indication
1.4.3 Europe Kyphoplasty Market, by End User
1.4.4 Europe Kyphoplasty Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Kyphoplasty Market by Product Type
4.1 Europe Accessories Market by Country
4.2 Europe Kyphoplasty Systems Market by Country
Chapter 5. Europe Kyphoplasty Market by Indication
5.1 Europe Osteoporosis Market by Country
5.2 Europe Others Market by Country
Chapter 6. Europe Kyphoplasty Market by End User
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Ambulatory Surgical Centers Market by Country
Chapter 7. Europe Kyphoplasty Market by Country
7.1 Germany Kyphoplasty Market
7.1.1 Germany Kyphoplasty Market by Product Type
7.1.2 Germany Kyphoplasty Market by Indication
7.1.3 Germany Kyphoplasty Market by End User
7.2 UK Kyphoplasty Market
7.2.1 UK Kyphoplasty Market by Product Type
7.2.2 UK Kyphoplasty Market by Indication
7.2.3 UK Kyphoplasty Market by End User
7.3 France Kyphoplasty Market
7.3.1 France Kyphoplasty Market by Product Type
7.3.2 France Kyphoplasty Market by Indication
7.3.3 France Kyphoplasty Market by End User
7.4 Russia Kyphoplasty Market
7.4.1 Russia Kyphoplasty Market by Product Type
7.4.2 Russia Kyphoplasty Market by Indication
7.4.3 Russia Kyphoplasty Market by End User
7.5 Spain Kyphoplasty Market
7.5.1 Spain Kyphoplasty Market by Product Type
7.5.2 Spain Kyphoplasty Market by Indication
7.5.3 Spain Kyphoplasty Market by End User
7.6 Italy Kyphoplasty Market
7.6.1 Italy Kyphoplasty Market by Product Type
7.6.2 Italy Kyphoplasty Market by Indication
7.6.3 Italy Kyphoplasty Market by End User
7.7 Rest of Europe Kyphoplasty Market
7.7.1 Rest of Europe Kyphoplasty Market by Product Type
7.7.2 Rest of Europe Kyphoplasty Market by Indication
7.7.3 Rest of Europe Kyphoplasty Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Partnerships, Collaborations and Agreements:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Stryker Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Geographical Expansions:
8.2.5.2 Approvals and Trials:
8.3 MicroPort Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 IZI Medical Products, LLC (Landauer, Inc.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Product Launches and Product Expansions:
8.4.2.2 Acquisition and Mergers:
8.5 Merit Medical Systems, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Jiangsu Changmei Medtech Co., Ltd.
8.6.1 Company Overview
8.7 G21 S.r.l.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Approvals and Trials:
8.8 Seawon Meditech Co., Ltd.
8.8.1 Company Overview
8.9 joimax® GmbH
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Taeyeon Medical Co., Ltd.
8.10.1 Company Overview

Companies Mentioned

  • Medtronic PLC
  • Stryker Corporation
  • MicroPort Scientific Corporation
  • IZI Medical Products, LLC (Landauer, Inc.)
  • Merit Medical Systems, Inc.
  • Jiangsu Changmei Medtech Co. Ltd.
  • G21 S.r.l.
  • Seawon Meditech Co., Ltd.
  • joimax® GmbH
  • Taeyeon medical Co., Ltd.

Methodology

Loading
LOADING...